EthiFinance Ratings discontinues its Corporate Rating Methodology – Pharma Sector

Pharma Companies are now analysed using the General Corporate Rating Methodology.

As of the 15^th of July 2024, EthiFinance Ratings has decided to discontinue its Pharma Sector rating methodology.  Pharma Companies are now analysed using the General Corporate Rating Methodology. 

Our decision is based on the fact that Pharma companies can be adequately analysed, using our current General Corporate Rating Methodology, without the need for a sector-specific framework. 

Currently, EthiFinanceRatings rates one pharmaceutical company whose rating has not been affected by this change.